Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2014
06/26/2014US20140178371 Anti-angiogenesis therapy for the treatment of ovarian cancer
06/26/2014US20140178370 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1) pathway
06/26/2014US20140178369 Treatment with anti-vegf antibodies
06/26/2014US20140178368 Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer
06/26/2014US20140178363 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors
06/26/2014US20140178334 Methods and compositions for liquidation of tumors
06/26/2014US20140178333 Homogenous preparations of il-28 and il-29
06/26/2014US20140178332 IL-12/p40 BINDING PROTEINS
06/26/2014US20140178295 Method for Treating Psoriasis By Administering An Anti-IL-12 Antibody
06/26/2014US20140178294 Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration
06/26/2014DE212011100195U9 Antikörper, der das Tumorwachstum stoppt oder verzögert (Varianten) Antibody will stop tumor growth and delayed (variants)
06/25/2014EP2746396A1 Selective local inhibition of TNFR1-mediated functions at the site of antigen/allergen presentation
06/25/2014EP2746394A1 Antibody and antibody-containing composition
06/25/2014EP2746294A2 Antibodies
06/25/2014EP2745845A1 A method for preventing or treating an HIV infection
06/25/2014EP2745844A1 Molecular mimic mucosal aids vaccine
06/25/2014EP2744931A1 Soluble polypeptides
06/25/2014EP2744894A2 Production of infectious rna viruses in yeast
06/25/2014EP2744830A1 Lsr antibodies, and uses thereof for treatment of cancer
06/25/2014EP2744829A1 Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
06/25/2014EP2744828A1 Jaml specific binding agents, antibodies, and uses related thereto
06/25/2014EP2744827A1 Anti-tie2 antibodies uses thereof
06/25/2014EP2744826A1 Combination therapy with an anti - cd19 antibody and a purine analog
06/25/2014EP2744824A1 Neuregulin antibodies and uses thereof
06/25/2014EP2744518A2 Use of small molecules in methods for purification of biomolecules
06/25/2014EP2744517A2 Compositions and methods related to antibodies to staphylococcal protein a
06/25/2014EP2744516A1 Method for manufacturing protein solutions and their concentration
06/25/2014EP2744515A1 Combination therapy with an anti - cd19 antibody and a nitrogen mustard
06/25/2014EP2744514A1 Influenza h5 vaccines
06/25/2014EP2744513A1 Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
06/25/2014EP2744512A1 Use of neuregulin-4 for treatment of inflammatory bowel disease and necrotizing enterocolitis
06/25/2014EP2744511A1 Livestock improvement
06/25/2014EP2744508A1 Vegf-binding protein for blockade of angiogenesis
06/25/2014CN103890246A 可溶性多肽 Soluble polypeptides
06/25/2014CN103890183A 编码传染性喉气管炎病毒和新城疫病毒抗原的重组非致病性马立克氏病病毒构建体 Recombinant non-pathogenic Marek's disease virus-encoded ILT virus and Newcastle disease virus antigen constructs
06/25/2014CN103890177A Hpv嵌合颗粒 Hpv chimeric particles
06/25/2014CN103890173A 抗体和含有抗体的组合物 Antibodies and antibody-containing compositions
06/25/2014CN103890010A 抗-人-her3抗体及其用途 Anti - human -her3 antibodies and their use
06/25/2014CN103890007A 神经调节蛋白抗体及其用途 Neuregulin antibodies and their use
06/25/2014CN103890005A 稳定的多抗原结合抗体 More stable antigen-binding antibody
06/25/2014CN103890004A 由具有特定免疫显性表位的婴儿利什曼虫pfr1蛋白片段组成的嵌合分子可用于抗利什曼病的免疫疗法 Chimeric molecules by infants pfr1 Leishmania protein fragments having a particular composition of the immunodominant epitope can be used for anti-leishmaniasis immunotherapy
06/25/2014CN103889461A 保护细胞免于alu-rna诱导的变性和用于保护细胞的抑制剂 Protect cells from alu-rna-induced degeneration and inhibitors for protecting cells
06/25/2014CN103889452A 对t细胞活化性抗原和肿瘤抗原特异性的双特异性抗体及使用方法 Of t cell activation antigens and tumor antigen-specific bispecific antibodies and methods of use
06/25/2014CN103889451A 与C-Met相关的生物物质 Associated with the C-Met biomass
06/25/2014CN103889450A 用于人乳头状瘤病毒的疫苗及其使用方法 Human papilloma virus vaccines and methods of use for
06/25/2014CN103889449A 分子模拟粘膜艾滋病疫苗 Molecular modeling mucosal AIDS vaccine
06/25/2014CN103889448A 用于预防和治疗人、动物和细胞培养物感染的尿枝原体疫苗和抗体 Urinary Mycoplasma vaccines and antibodies for the prevention and treatment of human, animal and cell culture infected with
06/25/2014CN103889440A 用于癌症治疗和预防的涉及p62的方法和组合物 For cancer treatment and prevention methods and compositions involved in the p62
06/25/2014CN103889398A 口腔组合物 Oral composition
06/25/2014CN103882057A 携带p21ras单链抗体基因肿瘤特异性腺病毒载体的构建及其应用 P21ras carry tumor-specific single chain antibody gene adenovirus vector and its application
06/25/2014CN103882056A H5n1亚型禽流感与鸭肠炎病毒细菌人工染色体质粒 H5n1 Avian Influenza and duck enteritis virus bacterial artificial chromosome vector
06/25/2014CN103881985A 狂犬病病毒era减毒疫苗突变株及其制备方法和狂犬病活疫苗 Rabies virus mutant attenuated vaccine era and its preparation method and rabies vaccine
06/25/2014CN103881983A 重组犬流感病毒毒株、其制备方法及由其制备得到的疫苗 Recombinant canine influenza virus strains, methods for their preparation, and a vaccine prepared therefrom
06/25/2014CN103881982A 一种h9n2亚型禽流感病毒与鸭肠炎病毒活载体疫苗 One kind of h9n2 subtype avian influenza virus and duck enteritis virus live vector vaccine
06/25/2014CN103881981A 一种h5n1亚型禽流感病毒与鸭肠炎病毒活载体疫苗 One kind of h5n1 subtype avian influenza virus and duck enteritis virus live vector vaccine
06/25/2014CN103881956A 一种以乳酸乳球菌为载体的抗幽门螺杆菌疫苗 Lactococcus lactis is a kind of anti-Helicobacter pylori vaccine carrier
06/25/2014CN103880959A 一种抗p21ras蛋白的单链抗体及其应用 An anti-p21ras protein single-chain antibody and its application
06/25/2014CN103880958A 抗cd20抗原的抗体l4h6及其应用 Anti-cd20 antigens l4h6 Its Applications
06/25/2014CN103880957A 抗cd20抗原的抗体l1h1及其应用 Anti-cd20 antigens l1h1 Its Applications
06/25/2014CN103880956A 抗muc1单克隆抗体及其轻链和重链可变区 Monoclonal antibodies and anti muc1 light chain and heavy chain variable region
06/25/2014CN103880955A 肝细胞生长因子的特异性结合物 Hepatocyte growth factor specific binding
06/25/2014CN103880932A 猪瘟合成肽疫苗及其制备方法 Classical swine fever synthetic peptide vaccine and its preparation method
06/25/2014CN103877573A 伪狂犬病活疫苗的制备方法及其产品 Pseudorabies Vaccine preparation and products
06/25/2014CN103877572A 猪细小病毒病灭活疫苗的制备方法 Preparation of porcine parvovirus inactivated vaccine
06/25/2014CN103877571A 猪传染性胃肠炎灭活疫苗的制备方法及产品 Preparation TGE inactivated vaccine and products
06/25/2014CN103877570A 狂犬病活疫苗和制备狂犬病口服活疫苗的方法 The method of preparation of rabies vaccine and live oral rabies vaccine
06/25/2014CN103145806B 丙型肝炎病毒b细胞表位肽puhi26及其应用 Hepatitis C virus b-cell epitope peptide puhi26 Its Applications
06/25/2014CN103102394B 丙型肝炎病毒b细胞表位肽puhi49及其应用 Hepatitis C virus b-cell epitope peptide puhi49 Its Applications
06/25/2014CN102850454B 抗呼吸道合胞病毒的人单克隆抗体 Against respiratory syncytial virus human monoclonal antibody
06/25/2014CN102844661B 胃癌的生物标志物及其应用 Gastric cancer biomarkers and Applications
06/25/2014CN102746388B 一种链球菌保护性抗原C5a及其制备方法 A protective antigen streptococcal C5a and its preparation method
06/25/2014CN102349996B 人乳头瘤病毒药物组合物及其应用 Human papillomavirus pharmaceutical compositions and applications
06/25/2014CN102333791B 人源化k33n单克隆抗体的生成、表达和表征 K33n humanized monoclonal antibody generation, expression and characterization
06/25/2014CN102333539B 重组禽传染性鼻炎疫苗及其制备方法 Recombinant avian infectious coryza vaccine and its preparation method
06/25/2014CN102088994B 基于吲哚胺2,3-双加氧酶的免疫疗法 Based indolamine 2,3-dioxygenase immunotherapy
06/25/2014CN101628939B 治疗性人抗-il-1r1单克隆抗体 Therapeutic human monoclonal antibody anti--il-1r1
06/25/2014CN101355966B 双特异性单链Fv抗体分子及其使用方法 Bispecific single-chain Fv antibody molecules and methods of use
06/24/2014US8759493 MN gene and protein
06/24/2014US8759490 Antibodies that bind OV064 and methods of use therefor
06/24/2014US8759485 Chemokine binding activity of viral TNF receptors and related proteins
06/24/2014US8759483 HLA-A* 3303-restricted WT1 peptide and pharmaceutical composition comprising the same
06/24/2014US8759370 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
06/24/2014US8759310 Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8
06/24/2014US8759297 Genetically encoded multifunctional compositions bidirectionally transported between peripheral blood and the cns
06/24/2014US8759286 Pharmaceutical compositions comprising a VEGF-D polypeptide
06/24/2014US8759281 Antigen delivery vectors and constructs
06/24/2014US8759092 Preparation of vaccines using photosensitizer and light
06/24/2014US8759006 PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia
06/24/2014US8758811 Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery
06/24/2014US8758774 Bivalent vaccine for marine fish and method for making the same
06/24/2014US8758773 Vaccine candidates against Johne's disease
06/24/2014US8758772 Peptides and methods for the detection of lyme disease antibodies
06/24/2014US8758771 Bacterial virulence factors and uses thereof
06/24/2014US8758767 Antigens targeted by prevalent pathogennic T cells in type 1 diabetes and uses thereof
06/24/2014US8758766 Modified Streptococcus pneumoniae pneumolysin (PLY) polypeptides
06/24/2014US8758765 Compositions and methods related to Staphylococcal bacterium proteins
06/24/2014US8758764 Proteins and nucleic acids from meningitis/sepsis-associated Escherichia coli
06/24/2014US8758763 Archaeal polar lipid aggregates for administration to animals
06/24/2014US8758762 Method for preparing recombinant antigen complex using rotavirus nanoparticle
06/24/2014US8758761 Combination therapies for treating type 1 diabetes
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 1823